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Despite a growing body of evidence suggesting that short sleep duration may be linked to
adverse metabolic outcomes, how these associations differ between age groups remains
unclear. We use eight years of data from the UK National Diet and Nutritional Survey
(NDNS) (2008–2016) to analyse cross-sectional relationships between sleep duration and
metabolic risk in participants aged 11–70 years.
Methods
Participants (n = 2008) who provided both metabolic risk and sleep duration data were
included. Self-reported sleep duration was standardised by age, to account for differences
in age-related sleep requirements. A standardised metabolic risk score was constructed,
comprising: waist circumference, blood pressure, serum triglycerides, serum high-density
lipoprotein cholesterol, and fasting plasma glucose. Regression models were constructed
across four age groups from adolescents to older adults.
Results
Overall, decreased sleep duration (hrs) was associated with an increased metabolic risk
(standard deviations) with significant quadratic (B:0.028 [95%CI: 0.007, 0.050]) and linear
(B:-0.061 [95%CI: -0.111, -0.011]) sleep duration coefficients. When separated by age
group, stronger associations were seen among mid-aged adults (36-50y) (quadratic coeffi-
cient: 0.038 [95%CI: 0.002, 0.074]) compared to other age groups (e.g. adolescents (11-
18y), quadratic coefficient: -0.009 [95%CI: -0.042, 0.025]). An increased difference between
weekend and weekday sleep was only associated with increased metabolic risk in adults
aged 51–70 years (B:0.18 [95%CI: 0.005, 0.348]).
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Conclusions
Our results indicate that sleep duration is linked to adverse metabolic risk and suggest het-
erogeneity between age groups. Longitudinal studies with larger sample sizes are required
to explore long-term effects of abnormal sleep and potential remedial benefits.
Introduction
Cardiovascular disease and diabetes remain major public health concerns, with global burdens
expected to increase further in the next 10 years. Globally, the economic burden is estimated
to rise to at least $2.1 trillion for diabetes and to $1 trillion for cardiovascular diseases by 2030
[1, 2]. Indeed, the World Health Organisation has highlighted cardiovascular disease as the
leading cause of death worldwide and diabetes as another common cause of death [3]. Diet
and exercise are noted as two key risk factors for the development of metabolic diseases such
as cardiovascular disease and type 2 diabetes [4]. However, there have been suggestions that
other factors may play a modifiable role in the disease aetiologies, ranging from the gut micro-
biome to obesogenic HIV drugs [5]. One factor that may contribute to the development of
metabolic diseases is short sleep duration. Prior research has found associations between sleep
duration and both metabolic outcomes and diet quality in adults [6, 7]. As an example, Potter
et al., (2017) noted that, in cross-sectional data from UK adults, short sleep duration was asso-
ciated with increased body mass index (BMI) and several other metabolic markers [8]. Fur-
thermore, experimental studies in adults have suggested that a relationship between sleep
duration and metabolic outcomes may be mediated by increased dietary energy intake as well
as physical activity [9]. These findings are supported by a systematic review and meta-analysis
[10]. However, there have been relatively few studies analysing the impact of sleep on meta-
bolic outcomes in younger age groups or how these relationships may change with age. Early
research with relatively small sample sizes has indicated that sleep may influence metabolic
health in these age groups, for example by altering insulin sensitivity [11, 12]. Sleep duration
requirements are known to differ with age and, similarly, metabolic health is recognised as
varying with age [13, 14]. Adolescents are generally recommended 8 to 10 hours sleep per
night, decreasing with age to 7 to 8 hours sleep for adults aged over 65 [15–19]. The potentially
complex interplay between age, sleep architecture and metabolic health is an understudied
area of research. It has been suggested that factors such as diet may exert heterogeneous effects
depending on age and this could also be true of sleep health [20].
Two key metrics in describing sleep are quality and duration. Early research has suggested
the existence of associations between sleep duration and diet in young people [21, 22]. One of
these studies even noted that sleep restriction in childhood was associated with less favourable
BMI profiles in older age [23]. The authors concluded that addressing unhealthy sleep patterns
in childhood may offer some relief to the increasingly burdensome obesity crisis. However,
this remains a contestable area of research with others finding no such relationship in adoles-
cents [24, 25]. Similarly, according to a recent review, the evidence between fluctuations in
sleep duration between weekday and weekend nights and metabolic risk in young people is
limited and inconclusive [26]. There is, however, a growing body of literature indicating that
the difference between weekend and weekday night sleep is associated with unhealthy changes
to eating behaviours and diet quality, though this is heavily reliant on cross-sectional data [27,
28]. Eating behaviours and diet quality would likely lie on a causative pathway between sleep
and metabolic risk. In order to develop appropriate recommendations, there is a need for
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better understanding of how sleep affects metabolic risk amongst different age groups, which
may call for heterogeneous interventions.
In this study, we focus on sleep duration, which is both modifiable and relatively easy to
record [29]. Sleep duration can be self-reported or measured using medical devices including
polysomnograms [30]. Although device-measured sleep duration is more precise, self-reported
sleep duration is more feasible in large-scale epidemiological research, due to lower cost and
expertise requirements [31]. For the purposes of this study, we use self-reported sleep duration
as our exposure variable. There are a number of risk factors recognised to increase the risk of
developing heart disease, type 2 diabetes and strokes. Central obesity, insulin resistance, hyper-
tension and dyslipidaemia are particularly important and together they are defined as meta-
bolic syndrome [32]. In our analysis, we use a standardised metabolic risk score as an outcome
variable which incorporates these risk factors in order to ensure that our outcome variable
truly corresponds to risk of future health outcomes, including cardiovascular disease [33].
In this study, we use data from years 1–8 of the UK-representative ‘National Diet and
Nutrition Study Rolling Programme (NDNS)’ (2008–2016) to compare associations between
sleep duration and metabolic risk score in different age groups. Specifically, we aim to address
the research question: ‘How do associations between sleep duration and metabolic health differ
with age in the UK general population?’
Methods
Survey design and participants
The NDNS is an annual cross-sectional survey which assesses the diet of the general popula-
tion of the UK and includes measures on health. The NDNS aims to recruit 1000 participants
each year, comprising an equal ratio of adults (aged 19 years and older) and children (aged 1.5
to 18 years). Households were sampled from the U.K. Postcode Address File, a list of all
addresses in the U.K., with up to one adult and one child from each household eligible for
inclusion in the survey [34]. The survey consisted of two relevant stages, the first of which was
a computer-assisted interview and the second was a nurse visit in which blood samples and
waist circumference measurements were taken. Only a smaller proportion consent to the
nurse visit stage of the study, during which participants provide metabolic data [35]. Written
informed consent was obtained from all participants, or from their parents/guardians if aged
under 16 years. Ethical approval for the NDNS was obtained from the Oxfordshire A Research
Ethics Committee and the Cambridge South NRES Committee (Ref. No. 13/EE/0016). In this
analysis, we use data on participants aged from 11 to 70 years, combined from the first eight
years (2008–2016) of the NDNS to provide a sufficiently large sample size for age-based sub-
population analysis (Table 1) [36]. Metabolic data was unavailable to be analysed for partici-
pants aged below 11 years. An upper age limit of 70 years was set due to the likelihood of
unrecorded comorbidities affecting sleep in the elderly population. We excluded participants
from the analyses if they reported taking anti-hypertensive or lipid-lowering medication.
Sleep duration
In the survey, sleep data were reported in stage 1 (the interviewer stage) of the data collection,
in response to two questions which captured both weekend and weekday night sleep duration:
‘Over the last seven days, that is since (date), how long did you usually sleep for on week nights.
That is Sunday to Thursday nights?’ and ‘And over the last seven days, how long did you usually
sleep for on weekend nights. That is Friday and Saturday nights?’. We calculated sleep duration
as the average self-reported quantity of sleep obtained by respondents of the NDNS over the
seven days prior to questioning, over both weekday and weekend nights.
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To generate an age-adjusted measure of sleep duration that could be compared between
participants of different ages, we regressed sleep duration against age to produce a residual
sleep duration value for each participant. Since change in sleep with age is non-linear, a
restricted cubic spline regression was used, with 5 knots at ages 14, 26, 39, 50 and 65 years, to
ensure appropriate adjustment for age-related variation. The resultant ‘age-adjusted sleep’
measure indicates sleep duration in hours relative to the average value for that age. We also
subtracted the mean weekday night sleep duration from mean weekend sleep duration for
each participant to calculate a measure of difference in sleep duration (in hours) between
weekday and weekend nights.
Table 1. Descriptive statistics of the weighted sample, grouped by age category, from the NDNS Years 1–8.
Age category






(n = 2008) 11–18 19–35 36–50 51–70
(n = 431) (n = 423) (n = 632) (n = 522)
Sex (%) Male 47.3 50.7 48.5 47.4 44.6
Female 52.7 49.3 51.5 52.6 55.4
National Statistics socio-economic
classification (NS-SEC3) of household
reference person (%)
Managerial and professional occupations 50.0 41.9 42.2 56.2 54.5
Intermediate occupations 19.8 19.9 21.3 17.5 20.9
Routine and manual occupations 28.1 35.1 34.5 23.8 23.4
Never worked and other 2.1 3.1 2.0 2.5 1.2
Ethnic group (%) White 88.5 88.0 83.6 87.2 96.4
Mixed ethnic group 2.4 3.1 4.1 1.3 1.3
Black or Black British 2.5 2.1 3.9 2.8 0.7
Asian or Asian British 5.2 5.0 7.2 6.4 1.3
Any other group 1.4 1.8 1.2 2.2 0.3
Smoking status (%) Never a regular smoker 65.0 90.0 62.7 61.0 61.1
Ex-smoker 20.4 0.7 16.5 23.6 30.2
Current smoker 14.6 9.4 20.8 15.3 8.7
Screen time (hours/day) (s.d.) Mean screen time at home per day (computer use,
TV, DVD or video viewing)
5.0 (2.2) 5.9 (2.2) 5.3 (2.5) 4.7 (2.1) 4.8 (1.9)
Sleep duration (hours/day) (s.d.) Average sleep duration in seven days prior to
questioning
7.4 (1.2) 8.6 (1.3) 7.6 (1.1) 7.1 (1.2) 7.0 (1.1)
Average weeknight sleep (Sunday to Thursday) in
seven days prior to questioning
7.3 (1.3) 8.4 (1.5) 7.5 (1.1) 7.0 (1.2) 6.9 (1.2)
Average weekday sleep (Friday to Saturday) in seven
days prior to questioning
7.7 (1.5) 9.1 (1.8) 7.9 (1.5) 7.5 (1.4) 7.2 (1.2)
Difference between weekend and weekday
night sleep (hours) (s.d.)
Mean weekend sleep minus mean weekday night
sleep (Note: positive value indicates greater sleep at
the weekend)
0.4 (1.2) 0.7 (2.0) 0.4 (1.3) 0.5 (1.0) 0.3 (0.8)










Waist circumference (cm) 88.7 (13.9) 76.0 (10.7) 85.9 (13.6) 91.9 (13.1) 92.8 (12.8)
Triglycerides (mmol/L) 1.2 (0.8) 0.9 (0.5) 1.1 (0.7) 1.4 (1.1) 1.3 (0.7)
HDL (mmol/L) 1.5 (0.4) 1.4 (0.3) 1.4 (0.4) 1.4 (0.4) 1.6 (0.5)
Glucose (mmol/L) 5.1 (1.0) 4.8 (0.5) 4.9 (0.9) 5.2 (1.2) 5.3 (1.0)
Average blood pressure (mm/Hg) 97.2 (12.2) 88.3 (8.2) 93.8 (10.1) 99.0 (12.3) 102.4
(12.9)
https://doi.org/10.1371/journal.pone.0242852.t001
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Metabolic risk factors
To provide an overall measure of metabolic risk, we used metabolic risk z-scores (MetZscore)
[37–39]. Use of a continuous risk score, standardised for age, facilitates comparison across age
groups [40]. The MetZscore was based on the metabolic risk factors included in the definition
of metabolic syndrome from the National Cholesterol Education Program—Adult Treatment
Program III (NCEP-ATPIII): waist circumference, blood pressure (BP), serum triglycerides,
serum high-density lipoprotein (HDL) cholesterol, and fasting plasma glucose [41]. Metabolic
risk factors were measured during stage 2 (the nurse visit) of the data collection. Waist circum-
ference was measured at the midpoint between the iliac crest and lower rib, using a tape mea-
sure precise to the nearest 0.1cm. Systolic and diastolic BP values were measured in a seated
position ensuring that participants had not eaten, consumed alcohol, exercised, or smoked in
the preceding 30 minutes. Three BP readings were taken at one-minute intervals. Serum tri-
glycerides, serum HDL cholesterol and plasma glucose were measured from fasted blood sam-
ples, Details of each assay and their quality control data are provided in NDNS Appendix Q
[35].
The MetZscore was calculated, as has been described previously, by first standardising the
individual metabolic risk factors by regressing them onto selected demographic variables (age,
sex, ethnicity) [20, 37]. To account for the non-linearity of associations between age and meta-
bolic outcomes, a restricted cubic spline regression was applied to the weighted sample for
each outcome, with knots at ages 15, 20, 30, 40 and 50 years, to ensure appropriate adjustment
for age-related variation. The resulting residuals were standardised to give a mean of 0 and a
standard deviation (SD) of 1. Standardised HDL is inversely related to metabolic risk so it was
multiplied by -1. The residuals of systolic and diastolic BP were averaged to give a value of
mid-blood pressure. Z-scores for the individual risk factors were summed to create the MetZ-
score. This score was standardised to have a mean of 0, with a standard deviation of 1, within
the analysis population. A higher MetZscore is indicative of a less favourable metabolic syn-
drome profile.
Covariates
Age, sex, ethnicity, smoking and screen time were self-reported. Ethnicity was classified
according to five groups (white, mixed, black, Asian and other). Smoking was categorised into
three categories: ‘current smoker’, ‘ex-regular smoker’ and ‘never regular smoker’. Television
viewing time has been used as a covariate in comparable studies; the NDNS provided data on
television viewing together with other related activities to produce a measure of screen time
[23]. Screen time was reported in response to a series of questions on how much time partici-
pants spent watching DVDs, TV, or videos and computer use, before 6pm and after 6pm on
both weekends and weekday nights. These data were summed to create a single variable of
total weekly screen time. National statistics socio-economic classification (NSSEC) of the
household reference person was reported by the household reference person (defined as the
household member with the highest income), and classified into four groups: Managerial and
professional occupations; Intermediate occupations; Routine and manual occupations; and
Never worked or other [42]. We did not adjust for diet quality or physical activity as the litera-
ture suggests that these are likely to be on the causal pathway between sleep and metabolic out-
comes; this was not the case for screen time [9]. We considered inclusion of marital status,
alcohol intake and employment status as covariates, but these were not associated with the
exposure and outcome variables in our dataset.
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Statistical analysis
All the analyses were performed using R (version 3.6.0). The weights (blood sample weights)
provided with the NDNS dataset were applied to account for clustering and response biases. In
our descriptive analysis, sociodemographic factors, sleep and MetZscore were summarized
overall and by age category. 562 participants had missing screen time data, 40 had missing
socioeconomic classification data and 13 had missing data regarding smoking habits. Multiple
imputations by chained equations were used to impute missing data for covariates, under the
missing at random assumption, following recommendations from White et al. [43]. Twenty
imputed datasets were generated using the R command ‘mice()’. Each dataset was analysed
separately and results combined using Rubin’s rule [43].
We first tested associations between age-adjusted sleep and MetZscore across all age groups
combined. We compared linear and quadratic models, by calculating residual sum of squares
and Akaike information criterion (AIC), both of which indicated that the quadratic model pro-
vided a better fit to the data. Four age groups were constructed: 11-18y, 19-35y, 36-50y and 51-
70y and ‘age group’ was included as an interaction term in the regression models to test differ-
ences in association by age. Groups were designed such that they included a comparable num-
ber of participants whilst still separating adolescents from adults, due to their different sleep
duration requirements. Covariates were added in three stages: the first included no covariates to
produce an unadjusted model (model 1). Model 2 included sex, ethnicity and socioeconomic
classification and was performed with and without age group as a moderating factor. Finally,
model 3 included the previous covariates with the addition of screen time and smoking status.
Results
1. Characteristics of study population
Of 12097 participants who took part in years 1–8 of the NDNS, 7860 participants were aged
between 11 and 70 years. Of these, 2627 had complete metabolic data and 2365 had complete
sleep and metabolic risk data. A further 357 were excluded due to taking anti-lipid or anti-
hypertension medication. This left 2008 individuals in the analysis, with 21.5% aged 11 to 18y,
21.1% aged 19 to 35y, 31.5% aged 36 to 50y and 26.0% aged 51 to 70y. Descriptive data on the
study population are shown in Table 1.
The data show an average sleep duration of 7.4 hours per night overall, with more sleep
recorded in adolescents. Fig 1 illustrates the relationship between age and sleep duration. Sleep
duration decreases steeply with age through adolescence then slows but continues to decrease
as age increases.
Fig 1. The unadjusted relationship between sleep and age, across all age groups (95% CI shown in grey).
https://doi.org/10.1371/journal.pone.0242852.g001
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2. Relationship between sleep duration and metabolic outcomes
Overall, the results in Table 2 indicate that there is an association between increased sleep (in
hours) and reduced metabolic risk (in standard deviations) across all ages (quadratic term:
0.028 [95%CI: 0.007, 0.050, p = 0.01], linear term: -0.061 [95%CI: -0.111, -0.011, p = 0.02]).
When age categories are introduced, the association appears only in the 36–50 age group,
which suggests that the overall effect may be driven by the effect seen in this group. The coeffi-
cients presented in Table 2 refer to regression equation: y = ax2 + bx + cz + �, where y repre-
sents change in metabolic risk score, x represents age-adjusted sleep duration, z represents one
of the covariate terms and � represents the error term.
The positive quadratic term (0.028 [95%CI: 0.007, 0.050, p = 0.01]) in the results for all ages
combined indicate that as sleep duration increases away from the mean, its marginal effect on
metabolic risk increases. Therefore, the greater the reduction in sleep time, the larger the cor-
responding increase in metabolic risk, as illustrated in Fig 2. Fig 2 also suggests that sleep dura-
tions above the mean may be associated with increasing metabolic risk as sleep duration
increases; however, this effect is not significant.
When we compare the associations between different age groups, we see that for mid-aged
adults the coefficient of the quadratic sleep duration term (0.038 [95%CI: 0.002, 0.074,
p = 0.04]) is much larger than that seen in adolescents (-0.009 [95%CI: -0.042, 0.025,
p = 0.59]), suggesting that associations of metabolic risk with low sleep duration are less
marked in a younger population (Fig 3).
3. Relationship between intra-week sleep fluctuations and metabolic
outcomes
As shown in Table 3, the difference between weekday and weekend nightly sleep only appears
to be statistically significantly associated with metabolic outcomes in older adults, where it is
associated with increased metabolic risk. For adults aged between 51 and 70y, we see that
Table 2. Cross-sectional associations between sleep duration and metabolic risk score, presenting coefficients for both the quadratic sleep duration term and the
linear sleep duration term from the regression model.
Change in metabolic risk score (standard deviations) for sleep duration increase of one hour [95% CI]
Model 1, unadjusted Model 2, adjusted using basic covariates (sex,
ethnicity, socioeconomic classification)
Model 3, covariates: sex, ethnicity,




















All ages (n = 2008) 0.031 [0.010, 0.053]� -0.067[-0.118,
-0.016]�
0.031 [0.009, 0.053]� -0.069 [-0.120,
-0.019]�
0.028[0.007, 0.050]� -0.061 [-0.111,
-0.011]�
Adolescents 11–18
years (n = 431)
-0.010 [-0.039, 0.020] 0.052 [-0.020, 0.125] -0.006 [-0.039, 0.026] 0.047 [-0.031,0.125] -0.009 [-0.042, 0.025] 0.041 [-0.039, 0.121]
Young adults 19–
35 years (n = 423)




0.046 [0.009, 0.083]� -0.091 [-0.191, 0.009] 0.043[0.006, 0.079]� -0.096 [-0.193, 0.001] 0.038[0.002, 0.074]� -0.092 [-0.189, 0.005]
Older adults 51–
70 years (n = 522)
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where the difference between weekday (Sunday to Thursday) and weekend nights (Friday to
Saturday) increases by one hour, the MetZscore increases by 0.18 SD [95%CI: 0.005, 0.348,
p = 0.04]. The standardised score allows for estimation of centiles within a population and a
score of 0.18 corresponds to an increase of 7 percentiles.
Discussion
1. Summary of key findings
Our results illustrate that when all age groups are combined, longer sleep duration is associated
with more favourable metabolic health. When participants were stratified by age group, we
found that this effect was only observed in those aged between 36-50y. In the adolescent age
group in particular, the association between sleep and metabolic outcomes appears to be much
smaller than in mid-aged adults. It is likely that the mid-aged age group is driving the overall
effect. Whilst there may be adverse metabolic outcomes associated with prolonged sleep well
above average sleep duration, our findings do not indicate this. The difference between week-
end and weekday night sleep duration showed associations with metabolic outcomes only in
older age groups, with statistically significantly associations seen only in participants aged 51-
70y.
2. Strengths and limitations
A major strength of this study was the use of data from the NDNS, a national survey designed
to be representative of the UK general population. We used survey weights which are specifi-
cally designed to account for non-response to the blood sample collection so that, despite
some further participant exclusions specific to this study, our findings can be said to be broadly
Fig 2. Model predictions of metabolic risk score. Model predictions of metabolic risk score (with 95% confidence
intervals) as sleep durations vary above and below the mean (model 3, all age groups).
https://doi.org/10.1371/journal.pone.0242852.g002
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Fig 3. Model predictions of metabolic risk score by age group. Model predictions of metabolic risk score (with 95% confidence
intervals) as sleep durations vary above and below the mean, separated by age group (model 3, A: age 11 to 18 years, B: 19 to 35 years, C:
36 to 50 years, D: 51 to 70 years).
https://doi.org/10.1371/journal.pone.0242852.g003
Table 3. Cross-sectional associations between the difference between weekend and weekday night sleep and metabolic risk score.
Change in metabolic risk score (s.d.) for sleep duration or sleep duration increase of one hour [95%CI]
Unadjusted models Adjusted models using basic covariates (sex,
ethnicity, socioeconomic classification)
Adjusted models (covariates: sex, ethnicity,
socioeconomic classification, smoking, screen
time)
Coefficient of ‘difference between
weekday and weekend sleep’ term
Coefficient of ‘difference between weekday
and weekend sleep’ term
Coefficient of ‘difference between weekday and
weekend sleep’ term
All ages (n = 2008) 0.052 [-0.003,0.107] 0.048 [-0.008, 0.104] 0.051 [-0.007, 0.108]
Adolescents 11–18
years (n = 431)
0.026 [-0.020, 0.073] 0.021 [-0.030, 0.071] 0.015 [-0.037, 0.068]
Young adults 19–35
years (n = 423)
0.001 [-0.097, 0.098] -0.004 [-0.105, 0.096] 0.003 [-0.101, 0.107]
Mid-aged adults 36–50
years (n = 632)
0.096 [-0.043, 0.236] 0.105 [-0.034, 0.243] 0.104 [-0.033, 0.241]
Older adults 51–70
years (n = 522)
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reflective of the UK population across our included age range. However, the fact that the study
population, due to the ethnicity of the UK population, was mostly of white ethnicity is a limita-
tion and complicates the generalisability of the findings. The wide range of data included in
the NDNS survey, allow us to test, and where appropriate adjust for, all putative covariates.
We were able to exclude participants who were taking blood-pressure or lipid-lowering medi-
cations from the analysis, as this would have affected their metabolic risk profile, but unfortu-
nately data was unavailable to allow us to exclude participants taking medication for sleep-
related reasons. The NDNS has a well-defined methodology which is consistent between years
of the survey, allowing us to combine data across recent years of survey data. Survey data is
accompanied with much detail about the interviewer questions and measurement procedures,
to ensure that the results may be appropriately compared with those using other data.
Limitations include the self-reported assessment of sleep duration and use of cross-sectional
data. Personal experience is highly subjective and previous research has noted that people tend
to overestimate sleep duration when self-reporting [44–46]. It has also been noted that psycho-
social factors influence sleep reporting and whilst some groups might overestimate their sleep,
others may underestimate it [47]. The implication of this is that if the accuracy self-reported
sleep duration was associated with certain characteristics this would require correction to miti-
gate regression dilution bias, though no relevant associations were known at the time of this
study. It is possible to measure sleep clinically e.g. by polysomnogram or accelerometer study;
however, this was not used in the NDNS. Whilst more precise, the cost and participant burden
of polysomnograms reduces their applicability in clinical practice whereas self-reported sleep
duration can be routinely assessed in practice. Another limitation to our study is the use of
cross-sectional data, which is only capable of elucidating correlation between variables. Whilst
the literature generally favours that sleep health is a potential driver of metabolic health, the
possibility of reverse causality cannot be ignored.
3. Comparison with previous evidence
Our results indicated a decrease in sleep duration with age, consistent with existing literature.
It has been noted that people typically suffer from well-characterised changes to sleep architec-
ture as a function of ageing, with reduced sleep duration requirements [14, 48]. Indeed, sleep
duration recommendations tend to reflect this with adults recommended less sleep than ado-
lescents and children; some guidelines have now begun to refine sleep duration recommenda-
tions for the elderly [15]. In most cases, guidelines recommend around 8 to 10 hours sleep for
adolescents and 7 to 9 hours sleep for adults, with some recommending 7 to 8 hours sleep for
adults aged over 65 [15–19]. It is worth noting that the recommendations are designed with a
high granularity during adolescence and early childhood, such that they change at frequent
intervals with age in these age groups [18]. We were unable to draw conclusions on partici-
pants aged over 70 years old, due to the small number of eligible participants in the age group
as well as the high prevalence of comorbidities in this age group confounding metabolic health
measurements. However, it has been noted that, especially in this age group, additional charac-
teristics such as sleep quality have increased importance [14].
Others have reported that sleep durations both above and below recommendations are
associated with unfavourable health outcomes [14]. However, the metabolic health effects of
excessively prolonged sleep appear inconclusive in the literature. Our results are, overall, con-
sistent with a recent meta-analysis which found that short sleep duration is associated with
increased risk of metabolic syndrome and that prolonged sleep duration was not associated
with an increased risk [49]. However, at least one other study has suggested a U-shaped rela-
tionship between sleep duration and metabolic risk [50]. This is recognised as a conflicting
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area of research, with a systematic review noting that in another meta-regression analysis
authors found a relationship between long sleep and adverse metabolic outcomes; however,
they noted the need for future research exploring potential mechanisms and examining the
precise nature of any potential relationship [51]. Future research may also examine any reverse
causality and whether metabolic factors exert a causal effect in reducing sleep duration. There
is a notable shortage of longitudinal studies exploring the long term effects of sleep deprivation
on metabolic health. One prospective cohort study, conducted using New Zealand data, found
that short sleep as a child was linked with increased long-term metabolic risk at age 32 [23].
The authors concluded that addressing sleep duration may be a useful tool in stemming the
ongoing obesity epidemic. Our results suggest that strengths of associations between sleep
duration and metabolic health might be heterogeneous between age groups. The results of the
New Zealand study demonstrate long term effects of sleep deprivation in childhood; this is not
necessarily inconsistent with our findings, which explored cross-sectional associations. We
found that poor sleep was associated with adverse metabolic health effects in mid-aged adults,
but it is possible that the individuals driving the effect in this group also slept poorly in child-
hood, for these effects to only manifest later in life.
The difference between weekend and weekday nightly sleep has been identified as an
important avenue for future studies, with a limited body of literature at present [52]. Our
descriptive results agree with research noting that there is reduced intra-week sleep variability
in older age groups. One study noted that the difference between weekend and weekday sleep
may be a healthy phenomenon to compensate for reduced sleep on work/school nights [52]. It
may be that younger age groups are more resilient to short-term fluctuations in sleep duration.
Indeed, we see that the youngest age group (11–18 years) exhibits the largest mean difference
between weekend and weekday sleep, but showed no association of this difference with meta-
bolic risk score, whereas the oldest age group (51–70 years), where associations were seen,
exhibits the lowest. Older participants may be more likely to have flexible work times or be
retired and so may not have to wake up earlier on weekdays, compared to school or working
age participants. In older age groups, whose nightly sleep is typically less variable, any fluctua-
tions may be more likely to be pathological or deleterious to metabolic health. Notably, some
research has found differences between weekend and weekday sleep to be associated with
increased hunger, but not with increased fat mass [27]. However, conflicts in the literature are
apparent with another study finding that such difference was associated with an array of meta-
bolic risk factors, including adiposity, in adults aged 30–54 years [53].
It has been suggested that changes in circadian rhythm may impact dietary behaviours,
with a growing body of evidence, this includes a study noting that adults working night shifts
are more likely to choose unhealthy breakfast options than those working day shifts [27, 54,
55]. There is also a well-described relationship between shift work and metabolic risk factors,
though there is a need for further longitudinal studies in this area with some studies producing
discordant results [56, 57]. Overall, the literature suggests the existence of an understudied,
but complex, interplay between circadian rhythm shifts and health outcomes. The difference
between weekend and weekday sleep represents just one of several potential variables to denote
circadian rhythm variability.
4. Implications of findings
Sleep is currently an understated marker of human health at a population level; it is also sel-
dom considered in routine clinical practice as a health marker [58]. In order to warrant wide-
spread assessment of sleeping habits as a diagnostic marker or potential intervention we must
consider whether such application would be clinically useful. For this we need to consider
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feasible interventions, which will depend upon the underlying cause. Screening for poor sleep
duration may help in the diagnosis and prevention of mental and physical conditions, which
could be either a cause or consequence of poor sleep [59]. There are a range of causes of poor
sleep quality, some of which include: head trauma, depression, anxiety, arthritis, chronic pain
or hyperthyroidism [60, 61]. Identification that a patient is experiencing poor quality of sleep
is inadequate to formulate a diagnosis but it may aid in screening for a number of conditions,
including, but by no means limited to, insomnia. Indeed, the growing body of evidence
describing the effects of poor sleep has prompted calls for sleep to be routinely assessed in clin-
ical practice [62]. There may be scope to ask questions about sleep in the same way that ques-
tions about smoking, alcohol intake and lifestyle are asked. This would take seconds during
regular health check-ups, yet would enable access to an otherwise under-utilised health
marker. However, it should be noted that despite a growing body of evidence indicating that
poor sleep is associated with health outcomes, there is a shortage of studies assessing whether
improving sleep may have therapeutic, or public health, benefits in patients with unfavourable
metabolic risk factors [63].
Concluding remarks
The data presented in this paper indicate that the relationship between sleep duration and met-
abolic health exhibits heterogeneity between age groups. This reinforces the need for age-
appropriate guidelines when expanding the inclusion of sleep health in health consultations. It
also suggests that future research into the complications of poor sleep should not assume that
effects would be homogeneous between age groups. There is a growing body of literature sug-
gesting that irregular sleep patterns may act as an independent factor in influencing metabolic
outcomes. This remains an active area of research, with several gaps in the literature. Whilst
existing literature has separated children and adolescents from adults, our data suggest that
further age separation in young adults (19 to 35 years) and older adults may too be important.
This study is not able to elucidate a causal relationship between poor sleep and poor metabolic
outcomes, which would require longitudinal studies. Further research may include examining
other outcomes affected by sleep that may feed into metabolic pathways associated with less
favourable metabolic profiles. Technological advancements, including fitness trackers and
smart watches capable of monitoring sleep, may soon offer precise measurements of sleep
duration and propel future research in the field.
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